All updated as on -
With a valuation of $642.29M in 2023, the parenteral lipid emulsion market is expected to expand from 2024–2031 at a CAGR (compound annual growth rate) of 8.3 percent.
The market is being driven by a number of causes, including the increasing number of cases of hospital malnutrition, cancer, gastrointestinal diseases, and other chronic illnesses. A major issue in hospitals throughout Europe is hospital malnutrition.Extended hospital stays, heightened risk of complications, and increased death rates are some of the unfavorable outcomes that might result from it. Forty percent of European Union adult hospital patients are undernourished, says Specialized Nutrition Europe. Over in Europe, malnutrition is thought to cost 136.8 billion USD (or 120 billion EUR).According to the National Library of Medicine, there have been disturbingly high rates of malnutrition in European hospitals, with a prevalence of 37% and an incidence of 21%.
The purpose of this research is to show vendors where there is potential in the market by breaking it down into different regions and sectors. It was critical to comprehend the present state of the market and its projected future growth in order to assess the opportunity. The market is being predicted by meticulously comparing consumption and production habits. Market segment growth, scenario-based research, revenue growth of important market vendors, and growth of the adjacent market are additional elements taken into account when forecasting the market.
We estimated the market size using a top-down and bottom-up strategy, and we validated our estimates using interviews from industry professionals. We determined the Pharmaceuticals by aggregating market segments, the Pharmaceuticals' contribution to Biotechnology and Life Sciences, and vendor share, all while keeping the market's characteristics in mind. In order to ascertain the market's growth, many aspects were discovered and their impacts were examined. These elements included drivers, trends, restraints, and opportunities. We have studied the market's growth year-on-year to have a better grasp of the market's expansion. Growth patterns were also determined by comparing historic growth rates.
Because the elderly cannot meet their nutritional needs through the enteral route, parenteral nutrition is becoming more common among this population. Nutritional status is inversely related to hospital stays, recovery times from acute illnesses, and problems in the elderly. Parenteral lipid emulsions are more commonly used by critically ill patients due to a number of factors, including the increasing number of elderly patients, the high prevalence of chronic diseases such as Alzheimer's and inflammatory bowel disease, and an increase in the demand for these emulsions to meet nutritional needs.
Also projected to propel the market is a rise in the number of strategic initiatives made by top manufacturers to broaden their product reach and presence. The creation of new lipid emulsions is expected to spur market expansion, thanks to substantial investments, new product lines, and research projects. As an example, Baxter included Finomel in its parenteral nutrition portfolio and announced its debut in Europe in July 2019. Hybrid lipid emulsions, which include two or more sources like soybean and olive oil, are one example of an innovative product that is likely to drive market expansion.
Parenteral lipid emulsion was one of several healthcare products and services hit hard by the COVID-19 epidemic. Specialized care was necessary for critically sick patients, especially those who tested positive for COVID-19. A patient's immune system was compromised and other systems were disrupted by COVID-19. For example, gastrointestinal issues, including gastrointestinal hypomotility, manifested in almost 50% of the critically ill COVID-19 patients, as reported in a paper published in the Elsevier Public Health Emergency Collection. There was an uptick in the worldwide and national use of PN since patients also reported a wide range of additional abdominal issues.Also contributing to the market rise was the fact that multiple studies provided justification for the use of PN for patients experiencing the increased malnutrition problems that occurred during the epidemic. The Journal of the Academy of Nutrition and Dietetics reported, for example, that many COVID-19 patients hospitalized for intensive care units experienced acute malnutrition. So, during the pandemic, PN products saw a surge in market utilization.
Report Coverage
Global Parenteral Lipid Emulsion research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Parenteral Lipid Emulsion report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Parenteral Lipid Emulsion competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Parenteral Lipid Emulsion market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Parenteral Lipid Emulsion market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Parenteral Lipid Emulsion market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Baxter, Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Parenteral Lipid Emulsion market based on the below-mentioned segments:
Global Parenteral Lipid Emulsion Market, By Ingredient
1st Generation Lipid Emulsions
2nd Generation Lipid Emulsions
3rd Generation Lipid Emulsions
Global Parenteral Lipid Emulsion market, Regional Analysis
The market is being driven by a number of causes, including the increasing number of cases of hospital malnutrition, cancer, gastrointestinal diseases, and other chronic illnesses. A major issue in hospitals throughout Europe is hospital malnutrition.Extended hospital stays, heightened risk of complications, and increased death rates are some of the unfavorable outcomes that might result from it. Forty percent of European Union adult hospital patients are undernourished, says Specialized Nutrition Europe. Over in Europe, malnutrition is thought to cost 136.8 billion USD (or 120 billion EUR).According to the National Library of Medicine, there have been disturbingly high rates of malnutrition in European hospitals, with a prevalence of 37% and an incidence of 21%.
The purpose of this research is to show vendors where there is potential in the market by breaking it down into different regions and sectors. It was critical to comprehend the present state of the market and its projected future growth in order to assess the opportunity. The market is being predicted by meticulously comparing consumption and production habits. Market segment growth, scenario-based research, revenue growth of important market vendors, and growth of the adjacent market are additional elements taken into account when forecasting the market.
We estimated the market size using a top-down and bottom-up strategy, and we validated our estimates using interviews from industry professionals. We determined the Pharmaceuticals by aggregating market segments, the Pharmaceuticals' contribution to Biotechnology and Life Sciences, and vendor share, all while keeping the market's characteristics in mind. In order to ascertain the market's growth, many aspects were discovered and their impacts were examined. These elements included drivers, trends, restraints, and opportunities. We have studied the market's growth year-on-year to have a better grasp of the market's expansion. Growth patterns were also determined by comparing historic growth rates.
Because the elderly cannot meet their nutritional needs through the enteral route, parenteral nutrition is becoming more common among this population. Nutritional status is inversely related to hospital stays, recovery times from acute illnesses, and problems in the elderly. Parenteral lipid emulsions are more commonly used by critically ill patients due to a number of factors, including the increasing number of elderly patients, the high prevalence of chronic diseases such as Alzheimer's and inflammatory bowel disease, and an increase in the demand for these emulsions to meet nutritional needs.
Also projected to propel the market is a rise in the number of strategic initiatives made by top manufacturers to broaden their product reach and presence. The creation of new lipid emulsions is expected to spur market expansion, thanks to substantial investments, new product lines, and research projects. As an example, Baxter included Finomel in its parenteral nutrition portfolio and announced its debut in Europe in July 2019. Hybrid lipid emulsions, which include two or more sources like soybean and olive oil, are one example of an innovative product that is likely to drive market expansion.
Parenteral lipid emulsion was one of several healthcare products and services hit hard by the COVID-19 epidemic. Specialized care was necessary for critically sick patients, especially those who tested positive for COVID-19. A patient's immune system was compromised and other systems were disrupted by COVID-19. For example, gastrointestinal issues, including gastrointestinal hypomotility, manifested in almost 50% of the critically ill COVID-19 patients, as reported in a paper published in the Elsevier Public Health Emergency Collection. There was an uptick in the worldwide and national use of PN since patients also reported a wide range of additional abdominal issues.Also contributing to the market rise was the fact that multiple studies provided justification for the use of PN for patients experiencing the increased malnutrition problems that occurred during the epidemic. The Journal of the Academy of Nutrition and Dietetics reported, for example, that many COVID-19 patients hospitalized for intensive care units experienced acute malnutrition. So, during the pandemic, PN products saw a surge in market utilization.
Report Coverage
Global Parenteral Lipid Emulsion research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Parenteral Lipid Emulsion report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Parenteral Lipid Emulsion competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Parenteral Lipid Emulsion market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Baxter, Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Parenteral Lipid Emulsion Market from 2021 to 2031.
- Market Forecast for Parenteral Lipid Emulsion Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Parenteral Lipid Emulsion competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Parenteral Lipid Emulsion
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Parenteral Lipid Emulsion market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Parenteral Lipid Emulsion market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Baxter, Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A.
Primary Target Market
- Market Players of Parenteral Lipid Emulsion
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Parenteral Lipid Emulsion market based on the below-mentioned segments:
Global Parenteral Lipid Emulsion Market, By Ingredient
1st Generation Lipid Emulsions
2nd Generation Lipid Emulsions
3rd Generation Lipid Emulsions
Global Parenteral Lipid Emulsion market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive parenteral lipid emulsion market market research and competitor analysis for your business to help you develop more profound insights into the parenteral lipid emulsion market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the parenteral lipid emulsion market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.